loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 22341 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 LIRAGLUTIDE RECOMBINANT (1)

filter

01 NOVO NORDISK INC (1)

filter

01 SOLUTION;SUBCUTANEOUS (1)

filter

01 18MG/3ML (6MG/ML) (1)

filter

01 USA (1)

URL Supplier Web Content
SOLUTION;SUBCUTANEOUS
18MG/3ML (6MG/ML)
VICTOZA
USA
22341
2010-01-25
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 22341

Looking for CTD TGA MCC DOSSIER APPLICATION 22341 1

19

Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is LIRAGLUTIDE RECOMBINANT, with a corresponding application number 22341 and regulatory information .

proudly manufactured in the

approval since 2010-01-25

Novo Nordisk's VICTOZA SOLUTION;SUBCUTANEOUS, medication with 18MG/3ML (6MG/ML) of LIRAGLUTIDE RECOMBINANT.

Post Enquiry
POST ENQUIRY